Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold

N Engl J Med. 2014 Aug 28;371(9):796-7. doi: 10.1056/NEJMp1405158.

Authors

Peter J Neumann¹, Joshua T Cohen, Milton C Weinstein

Affiliation

¹ From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (P.J.N., J.T.C.), and the Department of Health Policy and Management, Harvard School of Public Health (M.C.W.) - both in Boston.

PMID: 25162885
DOI: 10.1056/NEJMp1405158

No abstract available

MeSH terms

Cost-Benefit Analysis*
Health Care Costs*
Health Policy / economics*
Humans
Models, Economic
Quality-Adjusted Life Years*
United States